Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients - Torriani, Francesca J; Rodriguez-Torres, Maribel; Rockstroh, Jürgen K; Lissen, Eduardo; Gonzalez-García, Juan; Lazzarin, Adriano; Carosi, Giampiero; Sasadeusz, Joseph; Katlama, Christine; Montaner, Julio; Sette, Hoel; Passe, Sharon; et al. (The New England journal of medicine, 2004)
Keywords: Acquired immune deficiency syndrome; Adult; AIDS; Antiretroviral drugs; Antiviral Agents - adverse effects; Antiviral Agents - therapeutic use; Biological and medical sciences; Drug therapy; Drug Therapy, Combination; Female; General aspects; Genotype; Hepacivirus - drug effects; Hepacivirus - genetics; Hepatitis; Hepatitis C Antibodies - blood; Hepatitis C virus; Hepatitis C, Chronic - complications; Hepatitis C, Chronic - drug therapy; HIV; HIV Infections - complications; Human immunodeficiency virus; Human viral diseases; Humans; Infectious diseases; Interferon-alpha - adverse effects; Interferon-alpha - therapeutic use; Male; Medical sciences; Polyethylene Glycols; Recombinant Proteins; Ribavirin - adverse effects; Ribavirin - therapeutic use; RNA, Viral - blood; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Viral hepatitis; Infection; Medicine; Immunopathology; Chronic; Peginterferon alfa-2a; Viral disease; Digestive diseases; Hepatic disease; AIDS; Immune deficiency; Ribavirin; Viral hepatitis C